Stifel raised the firm’s price target on Evolus to $25 from $23 and keeps a Buy rating on the shares. Evolus reiterated “strong” 2024 revenue guidance, representing growth still at multiples of the market, and accelerated expectations of achieving profitability now for Q4 and FY25, despite 2024 being a year of continued execution for account penetration and growth, geographic expansion, continued development and regulatory filings, the analyst tells investors in a post-earnings note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on EOLS:
- EOLS Upcoming Earnings Report: What to Expect?
- Evolus upgraded to Overweight from Equal Weight at Barclays
- Evolus Stock (NASDAQ:EOLS) Spikes; Analysts See Significant Upside
- Evolus sees FY24 revenue $255M-$265M, consensus $253.27M
- Evolus sees Q4 revenue $61M, consensus $56.97M
Questions or Comments about the article? Write to editor@tipranks.com